A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection
Clinical trial NCT05763576 · TERMINATED
Trial details
- NCT number
- NCT05763576
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-28
- Primary completion
- 2024-12-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.